Tsao A-N, Chuang Y-S, Lin Y-C, Su Y, Chao T-C. Dinaciclib inhibits the stemness of two subtypes of human breast cancer cells by targeting the FoxM1 and Hedgehog signaling pathway. Oncol Rep. 2022;47(5). Google ScholarPubMedLog in or register to post comments